日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Editorial: Recent advances in oncolytic virus therapy for brain tumors

社论:溶瘤病毒疗法治疗脑肿瘤的最新进展

Askari, Fatemeh Sana; Mohebbi, Alireza; Ning, Jianfang; Kurozumi, Kazuhiko; Wakimoto, Hiroaki

Correction to: Functional virus‑specific memory T cells survey glioblastoma

更正:功能性病毒特异性记忆T细胞监测胶质母细胞瘤

Ning, Jianfang; Gavil, Noah V; Wu, Shaoping; Wijeyesinghe, Sathi; Weyu, Eyob; Ma, Jun; Li, Ming; Grigore, Florina-Nicoleta; Dhawan, Sanjay; Skorput, Alexander G J; Musial, Shawn C; Chen, Clark C; Masopust, David; Rosato, Pamela C

PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response

PI3Kγ抑制剂可抑制胶质母细胞瘤微环境中小胶质细胞/肿瘤相关巨噬细胞(TAM)的积累,从而促进替莫唑胺的卓越疗效。

Li, Jie; Kaneda, Megan M; Ma, Jun; Li, Ming; Shepard, Ryan M; Patel, Kunal; Koga, Tomoyuki; Sarver, Aaron; Furnari, Frank; Xu, Beibei; Dhawan, Sanjay; Ning, Jianfang; Zhu, Hua; Wu, Anhua; You, Gan; Jiang, Tao; Venteicher, Andrew S; Rich, Jeremy N; Glass, Christopher K; Varner, Judith A; Chen, Clark C

Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair.

PARP抑制剂恢复错配修复缺陷型胶质母细胞瘤对替莫唑胺的敏感性与碱基切除修复无关

Higuchi Fumi, Nagashima Hiroaki, Ning Jianfang, Koerner Mara V A, Wakimoto Hiroaki, Cahill Daniel P

CSIG-29. THE DUAL PI3K/mTOR-PATHWAY INHIBITOR GDC-0084 ACHIEVES ANTITUMOR ACTIVITY IN BREAST CANCER BRAIN METASTASES IN VITRO AND IN VIVO

CSIG-29. 双重PI3K/mTOR通路抑制剂GDC-0084在体外和体内均能抑制乳腺癌脑转移瘤的生长。

Wang, Guannan; Guo, Chun; Zhao, Hui; Pan, Zhenzhen; Zhu, Faliang; Zhang, Lining; Wang, Qun; Ippen, Franziska; Alvarez-Breckenridge, Christopher; Kuter, Benjamin; Fink, Alexandria; Bihun, Ivanna; Penson, Tristan; Ning, Jianfang; Wakimoto, Hiroaki; Brastianos, Priscilla

Immunovirotherapy for the treatment of glioblastoma

免疫病毒疗法治疗胶质母细胞瘤

Cheema, Tooba A; Fecci, Peter E; Ning, Jianfang; Rabkin, Samuel D